Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitubercular Agents”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT03423030
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Innovative Medicines for Tuberculosis 32
Not applicableStudy completedNCT00002032
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Early research (Phase 1)Study completedNCT02128308
What this trial is testing

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

Who this might be right for
Healthy
Seoul National University Hospital 16
Large-scale testing (Phase 3)UnknownNCT04117698
What this trial is testing

Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)

Who this might be right for
Uveitis, Anterior
Assistance Publique - Hôpitaux de Paris 116
Testing effectiveness (Phase 2)Study completedNCT02371681
What this trial is testing

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 262
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Early research (Phase 1)Study completedNCT01162486
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Johns Hopkins University 37
Not applicableStudy completedNCT00000959
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT00000638
What this trial is testing

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07303699
What this trial is testing

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Who this might be right for
Pulmonary Tuberculosis (TB)
Obafemi Awolowo University Teaching Hospital 80
Early research (Phase 1)Study completedNCT00004736
What this trial is testing

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 44
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Post-approval studies (Phase 4)WithdrawnNCT00964041
What this trial is testing

Once Weekly D-cycloserine for Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 127
Not applicableStudy completedNCT00002267
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Testing effectiveness (Phase 2)Looking for participantsNCT05807399
What this trial is testing

PanACEA - STEP2C -01

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 390
Testing effectiveness (Phase 2)Study completedNCT05005637
What this trial is testing

The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA

Who this might be right for
Tuberculous Uveitis
Fakultas Kedokteran Universitas Indonesia 78
Next Page